In this special episode of Industry Insights, we spoke with Dr. Rajendra Kumari and Dr. Gera Goverse from Crown Bioscience. Jen and Gera provide an overview of the cancer-immunity cycle and describe in vivo, in vitro, and ex vivo research tools to study immuno-oncology. In particular, they compare the benefits and limitations of in vivo models, ex vivo patient-derived tissues, and 2D and 3D cell cultures, talk about how organoids and high content imaging are impacting the field, and discuss a recent shift towards more physiologically relevant in vitro assays.
To watch our recent webinar, Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle, click here.
To read out recent blog article, The Cancer-Immunity Cycle: Research Solutions for Preclinical Immuno-Oncology, click here.
Read the full blog and watch the interview here.